TEST BANK FOR CLAYT
b b b
ON’S BASIC PHARMAC
b b
OLOGYFORNURSES 18
b b b
TH EDITIONBY WILLI
b b b
HNGANZ ALL CHAPTE b b
RS
,Chapter 1: Drug Definitions, Standards, and Information SourcesTe
b b b b b b b b
st Bank
b
MULTIPLEbCHOICE
1. WhatbisbthebnamebunderbwhichbabdrugbisblistedbbybthebU.S.bFoodbandbDrugbAdministrationb(
FDA)?
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS:b C
ThebofficialbnamebisbthebnamebunderbwhichbabdrugbisblistedbbybthebFDA.bThebbrandbname,borbtr
ademark,bisbthebnamebgivenbtobabdrugbbybitsbmanufacturer.bThebnonproprietary,borbgeneric,bna
mebisbprovidedbbybthebU.S.bAdoptedbNamesbCouncil.
DIF: CognitivebLevel:bKnowledge REF:bbbp.b1
OBJ:b2bTOP:b NursingbProcessbStep:bAssessment
MSC:b NCLEXbClientbNeedsbCategory:bSafe,bEffectivebCarebEnvironment
2. Whichbsourcebcontainsbinformationbspecificbtobnutritionalbsupplements?
a. USPbDictionarybofbUSANb&bInternationalbDrugbNames
b. NaturalbMedicinesbComprehensivebDatabase
c. UnitedbStatesbPharmacopoeia/NationalbFormularyb(USPbNF)
d. DrugbInteractionbFacts
ANS:b C
UnitedbStatesbPharmacopoeia/NationalbFormularybcontainsbinformationbspecificbtobnutritionalbs
upplements.bUSPbDictionarybofbUSANb&bInternationalbDrugbNamesbisbabcompilationbofbdrugbna
mes,bpronunciationbguide,bandbpossiblebfuturebFDAbapprovedbdrugs;bitbdoesbnotbincludebnutritio
nalbsupplements.bNaturalbMedicinesbComprehensivebDatabasebcontainsbevidencebbasedbinforma
tionbonbherbalbmedicinesbandbherbalbcombinationbproducts;bitbdoesbnotbincludebinformationbspec
ificbtobnutritionalbsupplements.bDrugbInteractionbFactsbcontainsbcomprehensivebinformationbonb
drugbinteractionbfacts;bitbdoesbnotbincludebnutritionalbsupplements.
DIF: CognitivebLevel:bKnowledge REF:bbbp.b2
OBJ:b4bTOP:b NursingbProcessbStep:bAssessment
MSC:b NCLEXbClientbNeedsbCategory:bPhysiologicalbIntegrity
3. Whatbisbthebmostbcomprehensivebreferencebavailablebtobresearchbabdrugbinteraction?
a. DrugbFactsbandbComparisons
b. DrugbInteractionbFacts
c. HandbookbonbInjectablebDrugs
d. Martindale—ThebCompletebDrugbReference
ANS:b B
, Stuvia.comb-
bThebMarketplacebtobBuybandbSellbyourbStudybMaterial
Firstbpublishedbinb1983,bDrugbInteractionbFactsbisbthebmostbcomprehensivebbookbavailablebonbd
rugbinteractions.bInbadditionbtobmonographsblistingbvariousbaspectsbofbdrugbinteractions,bthisbinf
ormationbisbreviewedbandbupdatedbbybanbinternationallybrenownedbgroupbofbphysiciansbandbpha
rmacistsbwithbclinicalbandbscientificbexpertise.
DIF: CognitivebLevel:bComprehension REF:bbbp.b3
OBJ:b3bTOP:b NursingbProcessbStep:bAssessment
MSC:b NCLEXbClientbNeedsbCategory:bPhysiologicalbIntegrity
4. Thebphysicianbhasbwrittenbanborderbforbabdrugbwithbwhichbthebnursebisbunfamiliar.bWhichbsectio
nbofbthebPhysicians’bDeskbReferenceb(PDR)bisbmostbhelpfulbtobgetbinformationbaboutbthisbdrug?
a. Manufacturer’sbsection
b. BrandbandbGenericbNamebsection
c. ProductbCategorybsection
d. ProductbInformationbsection
ANS:b B
Abphysician’sborderbwouldbincludebthebbrandband/orbgenericbnamebofbthebdrug.bThebalphabeticbi
ndexbinbthebPDRbwouldbmakebthisbsectionbthebmostbuserbfriendly.bBasedbonbabphysician’sborder,
bmanufacturer’s binformationbandbclassification binformationbwouldbnotbbebknown.bThebManufa
cturer’sbsectionbisbabrosterbofbmanufacturers.bThebProductbCategorybsectionblistsbproductsbsubdi
videdbbybtherapeuticbclasses,bsuchbasbanalgesics,blaxatives,boxytocics,bandbantibiotics.bThebPro
ductbInformationbsectionbcontainsbreprintsbofbthebpackagebinsertsbforbthebmajorbproductsbofbman
ufacturers.
DIF: CognitivebLevel:bComprehension REF:bbbp.b3
OBJ:b4bTOP:b NursingbProcessbStep:bPlanning
MSC:b NCLEXbClientbNeedsbCategory:bPhysiologicalbIntegrity
5. Whichbonlinebdrugbreferencebmakesbavailablebtobhealthbcarebprovidersbandbthebpublicbabstan
dard,bcomprehensive,bupbtobdateblookbupbandbdownloadablebresourcebaboutbmedicines?
a. AmericanbDrugbIndex
b. AmericanbHospitalbFormulary
c. DailyMed
d. Physicians’bDeskbReferenceb(PDR)
ANS:b C
DailyMedbmakesbavailablebtobhealthbcarebprovidersbandbthebpublicbabstandard,bcomprehensive,bu
pbtobdateblookbupbandbdownloadablebresourcebaboutbmedicines.bThebAmericanbDrugbIndexbisbnotb
appropriatebforbpatientbuse.bThebAmericanbHospitalbFormularybisbnotbappropriatebforbpatientbus
e.bThebPDRbisbnotbappropriatebforbpatientbuse.
DIF: CognitivebLevel:bKnowledge REF:bbbp.b4
OBJ:b5bTOP:b NursingbProcessbStep:bImplementation
MSC:b NCLEXbClientbNeedsbCategory:bPhysiologicalbIntegrity
6. WhichblegislationbauthorizesbthebFDAbtobdeterminebthebsafetybofbabdrugbbeforebitsbmarketing?
a. FederalbFood,bDrug,bandbCosmeticbActb(1938)
b. DurhambHumphreybAmendmentb(1952)
c. ControlledbSubstancesbActb(1970)
Thisbstudybsourcebwasbdownloadedbbyb100000761823232bfrombCourseHero.combonb04-12-2021b14:25:43bGMTb-05:00
https://www.coursehero.com/file/8889650/CH-1-Drug-definitions-standards-and-information-sources/
DownloaD
deodwn
by
lo:asdaem
dubeylo
:brAornibahso|ba|bbsbaim
ecule
inlo
@rognmaa.silo.c@
om
gmail.co
m
Distributionbofbthisbdocumentbisbillegal
, Stuvia.comb-
bThebMarketplacebtobBuybandbSellbyourbStudybMaterial
d. KefauverbHarrisbDrugbAmendmentb(1962)
ANS:b A
ThebFederalbFood,bDrug,bandbCosmeticbActbofb1938bauthorizedbthebFDAbtobdeterminebthebsafetyb
ofballbdrugsbbeforebmarketing.bLaterbamendmentsbandbactsbhelpedbtightenbFDAbcontrolbandbensu
rebdrugbsafety.bThebDurhambHumphreybAmendmentbdefinesbthebkindsbofbdrugsbthatbcannotbbebus
edbsafelybwithoutbmedicalbsupervisionbandbrestrictsbtheirbsalebtobprescriptionbbybablicensedbpracti
tioner.bThebControlledbSubstancesbActbaddressesbonlybcontrolledbsubstancesbandbtheirbcategorizat
ion.bThebKefauverbHarrisbDrugbAmendmentbensuresbdrugbefficacybandbgreaterbdrugbsafety.bDrugb
manufacturersbarebrequiredbtobprovebtobthebFDAbthebeffectivenessbofbtheirbproductsbbeforebmarke
tingbthem.
DIF: CognitivebLevel:bKnowledge REF:bbbp.b4
OBJ:b8bTOP:b NursingbProcessbStep:bAssessment
MSC:b NCLEXbClientbNeedsbCategory:bPhysiologicalbIntegrity
7. Meperidineb(Demerol)bisbabnarcoticbwithbabhighbpotentialbforbphysicalbandbpsychologicalbd
ependency.bUnderbwhichbclassificationbdoesbthisbdrugbfall?
a. I
b. II
c. III
d. IV
ANS:b B
Meperidineb(Demerol)bisbabSchedulebIIbdrug;bitbhasbabhighbpotentialbforbabusebandbmaybleadbtobse
verebpsychologicalbandbphysicalbdependence.bSchedulebIbdrugsbhavebhighbpotentialbforbabusebandb
nobrecognizedbmedicalbuse.bSchedulebIIIbdrugsbhavebsomebpotentialbforbabuse.bUsebmaybleadbtobl
owbtobmoderatebphysicalbdependenceborbhighbpsychologicalbdependence.bSchedulebIVbdrugsbhav
eblowbpotentialbforbabuse.bUsebmaybleadbtoblimitedbphysicalborbpsychologicalbdependence.
DIF: CognitivebLevel:bComprehension REF:bbbp.b4b|bp.b5
OBJ:b7bTOP:b NursingbProcessbStep:bAssessment
MSC:b NCLEXbClientbNeedsbCategory:bSafe,bEffectivebCarebEnvironment
8. WhatbwouldbthebFDAbdobtobexpeditebdrugbdevelopmentbandbapprovalbforbanboutbreakbofbs
mallpox,bforbwhichbtherebisbnobknownbtreatment?
a. Listbsmallpoxbasbabhealthborphanbdisease.
b. Omitbthebpreclinicalbresearchbphase.
c. Extendbthebclinicalbresearchbphase.
d. Fastbtrackbthebinvestigationalbdrug.
ANS:b D
OncebthebInvestigationalbNewbDrugbApplicationbhasbbeenbapproved,bthebdrugbcanbreceivebhighe
stbprioritybwithinbthebagency,bwhichbisbcalledbfastbtracking.bAbsmallpoxboutbreakbwouldbbecomeb
abprioritybconcernbinbthebworld.bOrphanbdiseasesbarebnotbresearchedbinbabprioritybmanner.bPrecli
nicalbresearchbisbnotbomitted.bExtendingbanybphasebofbthebresearchbwouldbmeanbablongerbtimebtob
developbabvaccine.bThebFDAbmustbensurebthatballbphasesbofbthebpreclinicalbandbclinicalbresearchb
phasebhavebbeenbcompletedbinbabsafebmanner.
DIF: CognitivebLevel:bKnowledge REF:bbbp.b7
OBJ:b8bTOP:b NursingbProcessbStep:bAssessment
Thisbstudybsourcebwasbdownloadedbbyb100000761823232bfrombCourseHero.combonb04-12-2021b14:25:43bGMTb-05:00
https://www.coursehero.com/file/8889650/CH-1-Drug-definitions-standards-and-information-sources/
DownloaD
deodwn
by
lo:asdaem
dubeylo
:brAornibahso|ba|bbsbaim
ecule
inlo
@rognmaa.silo.c@
om
gmail.co
m
Distributionbofbthisbdocumentbisbillegal
b b b
ON’S BASIC PHARMAC
b b
OLOGYFORNURSES 18
b b b
TH EDITIONBY WILLI
b b b
HNGANZ ALL CHAPTE b b
RS
,Chapter 1: Drug Definitions, Standards, and Information SourcesTe
b b b b b b b b
st Bank
b
MULTIPLEbCHOICE
1. WhatbisbthebnamebunderbwhichbabdrugbisblistedbbybthebU.S.bFoodbandbDrugbAdministrationb(
FDA)?
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS:b C
ThebofficialbnamebisbthebnamebunderbwhichbabdrugbisblistedbbybthebFDA.bThebbrandbname,borbtr
ademark,bisbthebnamebgivenbtobabdrugbbybitsbmanufacturer.bThebnonproprietary,borbgeneric,bna
mebisbprovidedbbybthebU.S.bAdoptedbNamesbCouncil.
DIF: CognitivebLevel:bKnowledge REF:bbbp.b1
OBJ:b2bTOP:b NursingbProcessbStep:bAssessment
MSC:b NCLEXbClientbNeedsbCategory:bSafe,bEffectivebCarebEnvironment
2. Whichbsourcebcontainsbinformationbspecificbtobnutritionalbsupplements?
a. USPbDictionarybofbUSANb&bInternationalbDrugbNames
b. NaturalbMedicinesbComprehensivebDatabase
c. UnitedbStatesbPharmacopoeia/NationalbFormularyb(USPbNF)
d. DrugbInteractionbFacts
ANS:b C
UnitedbStatesbPharmacopoeia/NationalbFormularybcontainsbinformationbspecificbtobnutritionalbs
upplements.bUSPbDictionarybofbUSANb&bInternationalbDrugbNamesbisbabcompilationbofbdrugbna
mes,bpronunciationbguide,bandbpossiblebfuturebFDAbapprovedbdrugs;bitbdoesbnotbincludebnutritio
nalbsupplements.bNaturalbMedicinesbComprehensivebDatabasebcontainsbevidencebbasedbinforma
tionbonbherbalbmedicinesbandbherbalbcombinationbproducts;bitbdoesbnotbincludebinformationbspec
ificbtobnutritionalbsupplements.bDrugbInteractionbFactsbcontainsbcomprehensivebinformationbonb
drugbinteractionbfacts;bitbdoesbnotbincludebnutritionalbsupplements.
DIF: CognitivebLevel:bKnowledge REF:bbbp.b2
OBJ:b4bTOP:b NursingbProcessbStep:bAssessment
MSC:b NCLEXbClientbNeedsbCategory:bPhysiologicalbIntegrity
3. Whatbisbthebmostbcomprehensivebreferencebavailablebtobresearchbabdrugbinteraction?
a. DrugbFactsbandbComparisons
b. DrugbInteractionbFacts
c. HandbookbonbInjectablebDrugs
d. Martindale—ThebCompletebDrugbReference
ANS:b B
, Stuvia.comb-
bThebMarketplacebtobBuybandbSellbyourbStudybMaterial
Firstbpublishedbinb1983,bDrugbInteractionbFactsbisbthebmostbcomprehensivebbookbavailablebonbd
rugbinteractions.bInbadditionbtobmonographsblistingbvariousbaspectsbofbdrugbinteractions,bthisbinf
ormationbisbreviewedbandbupdatedbbybanbinternationallybrenownedbgroupbofbphysiciansbandbpha
rmacistsbwithbclinicalbandbscientificbexpertise.
DIF: CognitivebLevel:bComprehension REF:bbbp.b3
OBJ:b3bTOP:b NursingbProcessbStep:bAssessment
MSC:b NCLEXbClientbNeedsbCategory:bPhysiologicalbIntegrity
4. Thebphysicianbhasbwrittenbanborderbforbabdrugbwithbwhichbthebnursebisbunfamiliar.bWhichbsectio
nbofbthebPhysicians’bDeskbReferenceb(PDR)bisbmostbhelpfulbtobgetbinformationbaboutbthisbdrug?
a. Manufacturer’sbsection
b. BrandbandbGenericbNamebsection
c. ProductbCategorybsection
d. ProductbInformationbsection
ANS:b B
Abphysician’sborderbwouldbincludebthebbrandband/orbgenericbnamebofbthebdrug.bThebalphabeticbi
ndexbinbthebPDRbwouldbmakebthisbsectionbthebmostbuserbfriendly.bBasedbonbabphysician’sborder,
bmanufacturer’s binformationbandbclassification binformationbwouldbnotbbebknown.bThebManufa
cturer’sbsectionbisbabrosterbofbmanufacturers.bThebProductbCategorybsectionblistsbproductsbsubdi
videdbbybtherapeuticbclasses,bsuchbasbanalgesics,blaxatives,boxytocics,bandbantibiotics.bThebPro
ductbInformationbsectionbcontainsbreprintsbofbthebpackagebinsertsbforbthebmajorbproductsbofbman
ufacturers.
DIF: CognitivebLevel:bComprehension REF:bbbp.b3
OBJ:b4bTOP:b NursingbProcessbStep:bPlanning
MSC:b NCLEXbClientbNeedsbCategory:bPhysiologicalbIntegrity
5. Whichbonlinebdrugbreferencebmakesbavailablebtobhealthbcarebprovidersbandbthebpublicbabstan
dard,bcomprehensive,bupbtobdateblookbupbandbdownloadablebresourcebaboutbmedicines?
a. AmericanbDrugbIndex
b. AmericanbHospitalbFormulary
c. DailyMed
d. Physicians’bDeskbReferenceb(PDR)
ANS:b C
DailyMedbmakesbavailablebtobhealthbcarebprovidersbandbthebpublicbabstandard,bcomprehensive,bu
pbtobdateblookbupbandbdownloadablebresourcebaboutbmedicines.bThebAmericanbDrugbIndexbisbnotb
appropriatebforbpatientbuse.bThebAmericanbHospitalbFormularybisbnotbappropriatebforbpatientbus
e.bThebPDRbisbnotbappropriatebforbpatientbuse.
DIF: CognitivebLevel:bKnowledge REF:bbbp.b4
OBJ:b5bTOP:b NursingbProcessbStep:bImplementation
MSC:b NCLEXbClientbNeedsbCategory:bPhysiologicalbIntegrity
6. WhichblegislationbauthorizesbthebFDAbtobdeterminebthebsafetybofbabdrugbbeforebitsbmarketing?
a. FederalbFood,bDrug,bandbCosmeticbActb(1938)
b. DurhambHumphreybAmendmentb(1952)
c. ControlledbSubstancesbActb(1970)
Thisbstudybsourcebwasbdownloadedbbyb100000761823232bfrombCourseHero.combonb04-12-2021b14:25:43bGMTb-05:00
https://www.coursehero.com/file/8889650/CH-1-Drug-definitions-standards-and-information-sources/
DownloaD
deodwn
by
lo:asdaem
dubeylo
:brAornibahso|ba|bbsbaim
ecule
inlo
@rognmaa.silo.c@
om
gmail.co
m
Distributionbofbthisbdocumentbisbillegal
, Stuvia.comb-
bThebMarketplacebtobBuybandbSellbyourbStudybMaterial
d. KefauverbHarrisbDrugbAmendmentb(1962)
ANS:b A
ThebFederalbFood,bDrug,bandbCosmeticbActbofb1938bauthorizedbthebFDAbtobdeterminebthebsafetyb
ofballbdrugsbbeforebmarketing.bLaterbamendmentsbandbactsbhelpedbtightenbFDAbcontrolbandbensu
rebdrugbsafety.bThebDurhambHumphreybAmendmentbdefinesbthebkindsbofbdrugsbthatbcannotbbebus
edbsafelybwithoutbmedicalbsupervisionbandbrestrictsbtheirbsalebtobprescriptionbbybablicensedbpracti
tioner.bThebControlledbSubstancesbActbaddressesbonlybcontrolledbsubstancesbandbtheirbcategorizat
ion.bThebKefauverbHarrisbDrugbAmendmentbensuresbdrugbefficacybandbgreaterbdrugbsafety.bDrugb
manufacturersbarebrequiredbtobprovebtobthebFDAbthebeffectivenessbofbtheirbproductsbbeforebmarke
tingbthem.
DIF: CognitivebLevel:bKnowledge REF:bbbp.b4
OBJ:b8bTOP:b NursingbProcessbStep:bAssessment
MSC:b NCLEXbClientbNeedsbCategory:bPhysiologicalbIntegrity
7. Meperidineb(Demerol)bisbabnarcoticbwithbabhighbpotentialbforbphysicalbandbpsychologicalbd
ependency.bUnderbwhichbclassificationbdoesbthisbdrugbfall?
a. I
b. II
c. III
d. IV
ANS:b B
Meperidineb(Demerol)bisbabSchedulebIIbdrug;bitbhasbabhighbpotentialbforbabusebandbmaybleadbtobse
verebpsychologicalbandbphysicalbdependence.bSchedulebIbdrugsbhavebhighbpotentialbforbabusebandb
nobrecognizedbmedicalbuse.bSchedulebIIIbdrugsbhavebsomebpotentialbforbabuse.bUsebmaybleadbtobl
owbtobmoderatebphysicalbdependenceborbhighbpsychologicalbdependence.bSchedulebIVbdrugsbhav
eblowbpotentialbforbabuse.bUsebmaybleadbtoblimitedbphysicalborbpsychologicalbdependence.
DIF: CognitivebLevel:bComprehension REF:bbbp.b4b|bp.b5
OBJ:b7bTOP:b NursingbProcessbStep:bAssessment
MSC:b NCLEXbClientbNeedsbCategory:bSafe,bEffectivebCarebEnvironment
8. WhatbwouldbthebFDAbdobtobexpeditebdrugbdevelopmentbandbapprovalbforbanboutbreakbofbs
mallpox,bforbwhichbtherebisbnobknownbtreatment?
a. Listbsmallpoxbasbabhealthborphanbdisease.
b. Omitbthebpreclinicalbresearchbphase.
c. Extendbthebclinicalbresearchbphase.
d. Fastbtrackbthebinvestigationalbdrug.
ANS:b D
OncebthebInvestigationalbNewbDrugbApplicationbhasbbeenbapproved,bthebdrugbcanbreceivebhighe
stbprioritybwithinbthebagency,bwhichbisbcalledbfastbtracking.bAbsmallpoxboutbreakbwouldbbecomeb
abprioritybconcernbinbthebworld.bOrphanbdiseasesbarebnotbresearchedbinbabprioritybmanner.bPrecli
nicalbresearchbisbnotbomitted.bExtendingbanybphasebofbthebresearchbwouldbmeanbablongerbtimebtob
developbabvaccine.bThebFDAbmustbensurebthatballbphasesbofbthebpreclinicalbandbclinicalbresearchb
phasebhavebbeenbcompletedbinbabsafebmanner.
DIF: CognitivebLevel:bKnowledge REF:bbbp.b7
OBJ:b8bTOP:b NursingbProcessbStep:bAssessment
Thisbstudybsourcebwasbdownloadedbbyb100000761823232bfrombCourseHero.combonb04-12-2021b14:25:43bGMTb-05:00
https://www.coursehero.com/file/8889650/CH-1-Drug-definitions-standards-and-information-sources/
DownloaD
deodwn
by
lo:asdaem
dubeylo
:brAornibahso|ba|bbsbaim
ecule
inlo
@rognmaa.silo.c@
om
gmail.co
m
Distributionbofbthisbdocumentbisbillegal